Belzutifan compared to everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
International Kidney Cancer Symposium (IKCS) 2021
The International Kidney Cancer Symposium (IKCS) 2021 took place in [...]
ASCO GU 2021: Immunotherapy for untreated non-clear cell kidney cancer
Results of a retrospective study presented during the 2021 American [...]
Effect of antibiotics on outcomes with systemic treatments for metastatic kidney cancer
The microbes in the gut (the gut microbiome) are a [...]
Effectiveness of targeted therapy after immunotherapy in metastatic kidney cancer patients
In this retrospective international study, the effectiveness of targeted therapy [...]
Real world use of targeted therapies in war veterans with kidney cancer
A retrospective study of the use of targeted therapies for [...]
Panobinostat plus everolimus not effective in metastatic kidney cancer
A recent phase I clinical trial assessed the combination of [...]
The effect of antibiotic use on outcomes with kidney cancer drug treatments
A recent study has looked at the use of antibiotics [...]
Effect of antibiotic use on outcomes with systemic therapies in metastatic kidney cancer
This study, published in European Urology Oncology this week, investigated [...]
